News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Common problem in GI oncology – NED in Non-Neuroendocrine Carcinoma
David W. Dodington/researchgate.net
Nov 18, 2024, 18:00

Common problem in GI oncology – NED in Non-Neuroendocrine Carcinoma

Thor Halfdanarson, Professor of Oncology at Mayo Clinic, shared an article by David W. Dodington on X:

“Here is a common problem in GI oncology, neuroendocrine differentiation (NED) in non-neuroendocrine carcinoma.

According to many studies, outcomes are worse if NED is present (colorectum, esophagus, stomach, lung and more).

I get asked this often…”

Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome.

Authors: David W. Dodington, et al.

Common problem in GI oncology - NED in Non-Neuroendocrine Carcinoma

cancer David W. Dodington GI oncology Mayo Clinic NED neuroendocrine differentiation Non-Neuroendocrine Carcinoma OncoDaily Oncology Serotonin Thor Halfdanarson
Special Coverage
Blog
Mar 22, 2025, 10:10
Corinne Leach: Innovation in Action at the CancerX Accelerator Moffitt Innovation Summit
Blog
Mar 22, 2025, 09:58
One story can change medical practice - EGFR Positive Lung Cancer UK
Science
Mar 22, 2025, 09:11
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Blog
Mar 22, 2025, 09:00
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Blog
Mar 22, 2025, 08:43
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Blog
Mar 22, 2025, 08:34
Registration open for the 8th "Combinations and Sequences in therapy" conference
Blog
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
Science
Mar 22, 2025, 07:56
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab
Blog
Mar 22, 2025, 07:49
UICC joined the Commonwealth Secretariat and the Lancet Oncology Commission in London
Blog
Mar 22, 2025, 07:42
President of Cairo University visited the Breast Cancer Hospital (NCI - New Cairo)
Blog
Mar 22, 2025, 07:31
Istvan Petak: We have officially launched BRECISE in Madrid
Science
Mar 22, 2025, 07:26
Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression